XML 42 R23.htm IDEA: XBRL DOCUMENT v3.24.1
Employee Benefits
12 Months Ended
Dec. 31, 2023
Employee Benefits [Abstract]  
Employee Benefits
Note 15:
Employee Benefits
 
401(k) Savings Plan
 
The Company has a retirement savings 401(k) plan covering substantially all employees.  Employees may contribute up to the maximum legal limit with the Bank matching up to 5% of the employee’s salary. Employer contributions charged to expense for the years ended December 31, 2023, 2022 and 2021 totaled $399,000, $366,000 and $267,000, respectively.
 
Stock-Based Compensation
 
The Company adopted a nonqualified incentive stock option plan (the “Bank7 Corp. 2018 Equity Incentive Plan”) in September 2018 and amended the Bank7 Corp. 2018 Equity Plan on May 20, 2020 adding an additional 507,500 shares to the plan. The Bank7 Corp. 2018 Equity Incentive Plan will terminate in September 2028, if not extended. Compensation expense, net of settlement of shares for payroll withholding related to the Plan for the years ended December 31, 2023, 2022 and 2021 totaled $2,164,000, $1,384,000 and $1,040,000, respectively. There were 637,371 shares available for future grants as of December 31, 2023.
 
The Company grants to employees and directors restricted stock units (RSUs) which vest ratably over one, three, four, five, or eight years and stock options which vest ratably over four years.  All RSUs and stock options are granted at the fair value of the common stock at the time of the award.  The RSUs are considered fixed awards as the number of shares and fair value are known at the date of grant and the fair value at the grant date is amortized over the vesting and/or service period.
 
The Company uses newly issued shares for granting RSUs and stock options.
 
The following table is a summary of the stock option activity under the Bank7 Corp. 2018 Equity Incentive Plan (dollar amounts in thousands, except per share data):

   
Options
   
Wgtd. Avg.
Exercise Price
 
Wgtd. Avg.
Remaining
Contractual Term
 
Aggregate
Intrinsic
Value
 
Year Ended December 31, 2023
                   
Outstanding at December 31, 2022
   
251,550
   
$
17.52
         
Options Granted
   
-
     
-
         
Options Exercised
   
(28,423
)
   
17.71
         
Options Forfeited
   
(2,188
)
   
15.15
         
Outstanding at December 31, 2023
   
220,939
     
17.52
     
5.64
   
$
2,172,070
 
Exercisable at December 31, 2023
   
173,684
     
18.04
     
5.27
   
$
1,616,278
 

    Options
   
Wgtd. Avg.
Exercise Price
 
Wgtd. Avg.
Remaining
Contractual Term
 
Aggregate
Intrinsic
Value
 
Year Ended December 31, 2022
                   
Outstanding at December 31, 2021
   
264,000
   
$
17.41
         
Options Granted
   
5,000
     
23.87
         
Options Exercised
   
(17,450
)
   
17.73
         
Options Forfeited
   
-
     
-
         
Outstanding at December 31, 2022
   
251,550
     
17.52
     
6.64
   
$
2,032,509
 
Exercisable at December 31, 2022
   
170,485
     
18.39
     
6.05
   
$
1,229,200
 


The fair value of each option grant is estimated on the date of grant using the Black-Scholes option-pricing model and is based on certain assumptions including risk-free rate of return, dividend yield, stock price volatility and the expected term.  The fair value of each option is expensed over its vesting period.

The following table shows the assumptions used for computing stock-based compensation expense under the fair value method on options granted during the year ended December 31, 2022, there were no options granted during the year ended December 2023:

   
For the Year
Ended
December 31,
2022
 
Risk-free interest rate
   
3.47
%
Dividend yield
   
1.96
%
Stock price volatility
   
34.92
%
Expected term
   
7.01
 


The following table summarizes share information about RSUs for the years ended December 31, 2023 and 2022:

   
Number of Shares
   
Wgtd. Avg.
Grant Date
Fair Value
 
Year Ended December 31, 2023
           
Outstanding at December 31, 2022
   
112,591
   
$
19.15
 
Shares granted
   
163,311
     
29.76
 
Shares vested
   
(57,354
)
   
19.48
 
Shares forfeited
   
(7,087
)
   
27.34
 
End of the period balance
   
211,461
   
$
26.98
 

   
Number of Shares
   
Wgtd. Avg.
Grant Date
Fair Value
 
Year Ended December 31, 2022
           
Outstanding at December 31, 2021
   
172,993
   
$
19.02
 
Shares granted
   
3,000
     
22.66
 
Shares vested
   
(61,902
)
   
18.88
 
Shares forfeited
   
(1,500
)
   
22.13
 
End of the period balance
   
112,591
   
$
19.15
 
 
As of December 31, 2023, there was approximately $4.5 million of unrecognized compensation expense related to 211,000 unvested RSUs and $156,000 of unrecognized compensation expense related to 221,000 unvested and/or unexercised stock options. The RSU expense is expected to be recognized over a weighted average period of 3.85 years, the stock option expense is expected to be recognized over a weighted average period of 1.29 years.